Alice Mogenet

Budigalimab: a viable option for patients with advanced solid tumors

INTRODUCTION: Immune checkpoint inhibitors transformed lung cancer treatment and prognosis, new drugs are currently being developed to continue to improve patient's outcome and especially surrogate immune checkpoint for each pharma company pipeline. AREAS COVERED: We conducted a...